The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim’s Jardiance for a potential ... Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in ...
Jardiance is propping up Boehringer’s balance sheets, generating annual sales of more than $2 billion for the German pharma last year, up 52.5% compared with 2017.